Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
|
|
|
12.
|
|
|
|
13.
|
Early molecular response and female sex strongly predict stable undetectable BCR-ABL1, the criteria for imatinib discontinuation in patients with CML. [electronic resource] by
- Branford, Susan
- Yeung, David T
- Ross, David M
- Prime, Jodi A
- Field, Chani R
- Altamura, Haley K
- Yeoman, Alexandra L
- Georgievski, Jasmina
- Jamison, Bronte A
- Phillis, Stuart
- Sullivan, Brad
- Briggs, Nancy E
- Hertzberg, Mark
- Seymour, John F
- Reynolds, John
- Hughes, Timothy P
Producer: 20130722
In:
Blood vol. 121
Availability: No items available.
|